Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru
about
The impact of being homeless on the unsuccessful outcome of treatment of pulmonary TB in São Paulo State, BrazilDrug-resistant tuberculosis in the WHO Western Pacific RegionDesigning and implementing a socioeconomic intervention to enhance TB control: operational evidence from the CRESIPT project in Peru.Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic DataMethodological Issues to Consider When Collecting Data to Estimate Poverty Impact in Economic Evaluations in Low-income and Middle-income CountriesA randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru.Improving active case finding for tuberculosis in South Africa: informing innovative implementation approaches in the context of the Kharitode trial through formative research.Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention.Health, healthcare access, and use of traditional versus modern medicine in remote Peruvian Amazon communities: a descriptive study of knowledge, attitudes, and practices.What can dissaving tell us about catastrophic costs? Linear and logistic regression analysis of the relationship between patient costs and financial coping strategies adopted by tuberculosis patients in Bangladesh, Tanzania and Bangalore, India.End TB strategy: the need to reduce risk inequalities.The Effects of Psycho-Emotional and Socio-Economic Support for Tuberculosis Patients on Treatment Adherence and Treatment Outcomes - A Systematic Review and Meta-AnalysisMitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia.The Financial Burden of Non-Communicable Chronic Diseases in Rural Nigeria: Wealth and Gender Heterogeneity in Health Care Utilization and Health ExpendituresFinancial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, ChinaFood assistance to tuberculosis patients: lessons from AfghanistanTB in Vulnerable Populations: The Case of an Indigenous Community in the Peruvian AmazonThe economic effects of supporting tuberculosis-affected households in Peru.Impact of Infection Control Measures to Control an Outbreak of Multidrug-Resistant Tuberculosis in a Human Immunodeficiency Virus Ward, PeruComparison of sputum collection methods for tuberculosis diagnosis: a systematic review and pairwise and network meta-analysis.The patient costs of care for those with TB and HIV: a cross-sectional study from South Africa.Effectiveness of a conditional cash transfer programme on TB cure rate: a retrospective cohort study in Brazil.Why wait? The social determinants underlying tuberculosis diagnostic delay.Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities.Improving tuberculosis diagnosis: Better tests or better healthcare?Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study.Mediating Effect of Repeated Tuberculosis Exposure on the Risk of Transmission to Household Contacts of Multidrug-Resistant Tuberculosis Patients.Measuring success: The challenge of social protection in helping eliminate tuberculosis.The Economic Impacts of Chronic Illness on Households of Patients in Ile-Ife, South-Western Nigeria.Analysis of multi drug resistant tuberculosis (MDR-TB) financial protection policy: MDR-TB health insurance schemes, in Chhattisgarh state, India.Socioeconomic and Behavioral Factors Associated with Tuberculosis Diagnostic Delay in Lima, Peru.MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care.Estimating the burden of antimicrobial resistance: a systematic literature review.World TB Day 2018: The Challenge of Drug Resistant Tuberculosis.Delay in seeking care for tuberculosis symptoms among adults newly diagnosed with HIV in rural Malawi.Measuring financial protection against catastrophic health expenditures: methodological challenges for global monitoring.Efficacy and Safety of Vitamin D Supplementation for Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.Cash interventions to improve clinical outcomes for pulmonary tuberculosis: systematic review and meta-analysis.Catastrophic costs of tuberculosis care: a mixed methods study from Puducherry, India.
P2860
Q28602110-364FFE81-5353-4FFB-8BCB-15D5DBA91C8EQ28650417-FDBD75E4-EF51-4DF3-9B61-ADAE38080CE1Q30662058-5C6BDC87-585F-42BA-831E-CEB7226846B4Q30980449-EB5EF7FF-7D9C-43A6-8F1F-5B1949618EADQ31037190-A3F3C9B4-2C7E-4C24-B82A-D0C3B9C8BF33Q33609582-952D356A-44FE-4162-830A-3E83CCAD24F0Q33743196-27D9F5E6-E8C7-494A-B5B6-BD958488FDBFQ34226104-8DBB0179-4FED-4B12-A77C-07ED3C050381Q35272877-D4736B79-4428-41CC-A255-8B13FB9138A7Q35817734-DAFBAB6F-BDE1-4462-B7B0-7B0E17C8BBC7Q35965610-D33F0EE5-F4B3-4596-B010-1BFA5FB2283BQ36001697-8BD68A02-7905-459B-966D-E35BF17EF065Q36128432-B1048C1B-C023-41CD-86F3-4757B5A9D88AQ36188586-E599A597-12A5-4760-9B4B-D533A8C831E3Q36286841-6C615DEB-3EAF-4A4A-9A35-D9ADBA52B07FQ37020530-2D985EFF-4289-4C0D-9381-39D953A513F6Q37351072-7470681B-233C-493D-8E67-60536C696693Q37388118-64128A90-9595-4182-97D8-B13AEA19B425Q37499488-216736E2-84A8-49CD-B3F6-759AFA4ED9A4Q38720366-A7BE99E0-42FB-4E80-9C56-19B1B7396468Q39278224-8C0FDF38-E889-444D-82DF-99F0DBE43DF1Q39529903-71C75931-3920-4422-8D79-D2717FC08FC9Q41930732-E2EA1A23-CFE5-45EE-BD0D-E89EAC933895Q42377337-D908BBDF-3799-432F-8E61-305E5206549EQ42587537-C8DBA9CA-348E-44C4-B86F-D9B374AF32C7Q42686074-E0F858E7-7377-4896-B7FF-74A7B38A4CFBQ43924045-F2B1EA6E-A8E7-49AA-B690-065EAA8EB8E6Q45933321-E7A54601-9CEB-42AA-A962-1E9BD85BB081Q46148135-343FAD28-85A4-4606-BBE9-1C13B81C3457Q47106079-05B78152-0989-4285-AA95-469796DC38C7Q48156501-FE4FCE86-FC51-41D8-8807-41E579417CAFQ52564906-B07CF96B-AEFB-4DAE-B1B9-F0822BBC0DC7Q52580516-809F4114-0049-40BD-AEE8-8FCAE357A5FFQ53689673-9A0F7D38-2F64-4946-9043-BAB13910E8B0Q53703022-00DA57AC-8B97-423F-8D27-FE3A689799DEQ54937126-4DD75A3C-B38A-44EF-A59A-C09256DF107FQ55265223-A31EDAC8-3335-4922-852E-C22B75D278ADQ55279948-1667CE41-491E-4197-AABC-4CF322137B5FQ55364610-106B2F91-8C48-40DB-B289-223D1F2DEF48Q55713427-902A01FD-14A3-4508-B349-BCF437ED47EB
P2860
Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Defining catastrophic costs an ...... prospective cohort study, Peru
@ast
Defining catastrophic costs an ...... prospective cohort study, Peru
@en
Defining catastrophic costs an ...... prospective cohort study, Peru
@nl
type
label
Defining catastrophic costs an ...... prospective cohort study, Peru
@ast
Defining catastrophic costs an ...... prospective cohort study, Peru
@en
Defining catastrophic costs an ...... prospective cohort study, Peru
@nl
prefLabel
Defining catastrophic costs an ...... prospective cohort study, Peru
@ast
Defining catastrophic costs an ...... prospective cohort study, Peru
@en
Defining catastrophic costs an ...... prospective cohort study, Peru
@nl
P2093
P2860
P50
P3181
P1433
P1476
Defining catastrophic costs an ...... prospective cohort study, Peru
@en
P2093
Arquímedes Gavino
Delia Boccia
Rosario Montoya
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1001675
P407
P577
2014-07-01T00:00:00Z